- 3/10 CC Syringe (0.3ml)
- 1/2 CC Syringe (0.5ml)
- 1CC Syringe (1ml)
- others
In the insulin syringes market, the syringes sold in 2023 are around 7,638.6 million units and are expected to register a CAGR of 2% during the forecast period, with a volume of 8,781.5 million units expected to be sold. Insulin syringes form an important segment of the healthcare industry, catering to the needs of patients suffering from diabetes. The major driving factors for this market include the rising prevalence of diabetes, increasing self-administration, developing technology, and an aging population.
According to its estimates, IDF reports a very high and increasing global prevalence of diabetes. In 2021, around 10.5% of the adult population of the age group 20-79 years was reported to be suffering from diabetes. That would amount to approximately 537 million adults in the world. Unfortunately, nearly half of these adults are unaware that they are affected by the condition. According to the forecast made by IDF, in 2045 there would be 783 million adults affected with diabetes, which is almost every 1 in 8 adults. This is driven by factors such as urbanization, aging of the population, decreased levels of physical activity, and rising overweight and obesity rates. Thus, an ever-growing number of people with diabetes-both Type 1 and Type 2-is one of the major factors driving the growth in the market for insulin syringes.
However, constraints such as competition from other insulin delivery devices, changeable regulatory environments, and economic factors are overcome by product innovation, home care settings, government programs, health initiatives, and expansion in emerging markets. Some current trends in the insulin syringes market are increasing demand for reusable and eco-friendly products, personalization and patient-centric design, wider adoption of smart insulin delivery systems, and expansion of e-commerce distribution.
Study Period
2024-2030Base Year
2023CAGR
2%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The major restraint in the insulin syringes market is the rising trend of moving toward alternate insulin delivery systems, like insulin pens, pumps, and continuous glucose monitors. These replacements tend to be more convenient, accurate, comfortable, and acceptable for patients since they promise better glycemic control with lesser frequency and painfulness. Insulin pens are convenient, delivering fixed doses of insulin, while pumps deliver continuous variable amounts of insulin, which more closely approximates the body's natural release of the hormone. Besides, the ability to integrate smart technology with pens and pumps that can perform in real-time by monitoring and adjusting dosages has increased treatment adherence. These innovative devices, although on the increase in developed economies, due also to friendly health care covers, are seen to replace insulin syringes, now belonging to the past, hence less demand for them. While still popular in low-income regions due to cost advantage, their market share has shrunk gradually in favor of modern alternatives to the syringe, especially in locations where affordability and access to technology have become relatively improved.
By Syringe Size
By Disease Type
By End User
In the insulin syringes market, the syringes sold in 2023 are around 7,638.6 million units and are expected to register a CAGR of 2% during the forecast period, with a volume of 8,781.5 million units expected to be sold.
Cardinal Health, Novo Nordisk, Trividia Health Inc., Arkray Inc., Ultimed Inc., Terumo Corporation
• Rising Prevalence of Diabetes
• Increasing Self-Administration
• Developing Technology
• Aging Population
• Competition From Other Insulin Delivery Devices
• Changeable Regulatory Environments
• Economic Factors
Asia-Pacific is the dominating region in the insulin syringe market.
1.Executive Summary |
2.Global Insulin Syringes Market Introduction |
2.1.Global Insulin Syringes Market - Taxonomy |
2.2.Global Insulin Syringes Market - Definitions |
2.2.1.Syringe Size |
2.2.2.Disease Type |
2.2.3.End User |
2.2.4.Region |
3.Global Insulin Syringes Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Insulin Syringes Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Insulin Syringes Market By Syringe Size, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. 3/10 CC Syringe (0.3ml) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. 1/2 CC Syringe (0.5ml) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. 1CC Syringe (1ml) |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Insulin Syringes Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Type 1 Diabetes |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Type 2 Diabetes |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Insulin Syringes Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals & Clinics |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Homecare Settings |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Insulin Syringes Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Insulin Syringes Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Syringe Size Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.3/10 CC Syringe (0.3ml) |
9.1.2.1/2 CC Syringe (0.5ml) |
9.1.3.1CC Syringe (1ml) |
9.1.4.others |
9.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Type 1 Diabetes |
9.2.2.Type 2 Diabetes |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals & Clinics |
9.3.2.Homecare Settings |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Insulin Syringes Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Syringe Size Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.3/10 CC Syringe (0.3ml) |
10.1.2.1/2 CC Syringe (0.5ml) |
10.1.3.1CC Syringe (1ml) |
10.1.4.others |
10.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Type 1 Diabetes |
10.2.2.Type 2 Diabetes |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals & Clinics |
10.3.2.Homecare Settings |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Insulin Syringes Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Syringe Size Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.3/10 CC Syringe (0.3ml) |
11.1.2.1/2 CC Syringe (0.5ml) |
11.1.3.1CC Syringe (1ml) |
11.1.4.others |
11.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Type 1 Diabetes |
11.2.2.Type 2 Diabetes |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals & Clinics |
11.3.2.Homecare Settings |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Insulin Syringes Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Syringe Size Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.3/10 CC Syringe (0.3ml) |
12.1.2.1/2 CC Syringe (0.5ml) |
12.1.3.1CC Syringe (1ml) |
12.1.4.others |
12.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Type 1 Diabetes |
12.2.2.Type 2 Diabetes |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals & Clinics |
12.3.2.Homecare Settings |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Insulin Syringes Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Syringe Size Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.3/10 CC Syringe (0.3ml) |
13.1.2.1/2 CC Syringe (0.5ml) |
13.1.3.1CC Syringe (1ml) |
13.1.4.others |
13.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Type 1 Diabetes |
13.2.2.Type 2 Diabetes |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals & Clinics |
13.3.2.Homecare Settings |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Cardinal Health |
14.2.2.Novo Nordisk |
14.2.3.Trividia Health Inc. |
14.2.4.Arkray Inc. |
14.2.5.Ultimed Inc. |
14.2.6.Terumo Corporation |
14.2.7.Allison Medical |
14.2.8.Medline Industries |
14.2.9.Smiths Medical |
14.2.10.Embecta Corp |
15. Research Methodology |
16. Appendix and Abbreviations |